To determine whether DSF/Cu can inhibit LGR5-positive cervical cancer stem-like cells in vivo, we used a xenograft model of modified LGR5-positive/negative SiHa and HeLa cells in BALB/c mice (Fig. 6a). The gene discussed is LGR5; the disease is cervical carcinoma.